Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Femoral Fractures

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Femoral Fractures in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Femoral Fractures: Fractures of the femur.

Research Excerpts

ExcerptRelevanceReference
"On Day 7 after trauma, mice were sacrificed, serum was collected, and splenic macrophages were evaluated for PGE(2), LTB(4), IL-6, TNF-alpha, and NO production."1.31NS-398 treatment after trauma modifies NF-kappaB activation and improves survival. ( Concannon, EM; Daly, JM; Mack Strong, VE; Mackrell, PJ; Mestre, JR; Schaefer, PA; Smyth, GP; Stapleton, PP, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mack Strong, VE1
Mackrell, PJ1
Concannon, EM1
Mestre, JR1
Smyth, GP1
Schaefer, PA1
Stapleton, PP1
Daly, JM1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Femoral Fractures

ArticleYear
NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
    The Journal of surgical research, 2001, Jun-01, Volume: 98, Issue:1

    Topics: Animals; Bacterial Infections; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibit

2001